Cargando…
地西他滨桥接异基因造血干细胞移植治疗骨髓增生异常综合征的疗效分析
OBJECTIVE: To evaluate the efficacy of decitabine (DAC) bridging therapy followed by allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with myelodysplastic syndrome (MDS). METHODS: The clinical characteristics and curative effect of MDS patients who received allo-HSCT from 2...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342152/ https://www.ncbi.nlm.nih.gov/pubmed/25778887 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.02.008 |
Ejemplares similares
-
地西他滨治疗骨髓增生异常综合征及相关肿瘤的疗效预测因素研究
Publicado: (2017) -
小剂量地西他滨治疗较低危骨髓增生异常综合征患者疗效初步观察
Publicado: (2017) -
地西他滨联合半量CAG方案治疗骨髓增生异常综合征伴原始细胞增多和急性髓系白血病伴骨髓增生异常相关改变
Publicado: (2018) -
含地西他滨预处理方案异基因造血干细胞移植治疗骨髓增生异常综合征/慢性粒-单核细胞白血病的疗效及安全性
Publicado: (2019) -
异基因造血干细胞移植治疗骨髓增生异常综合征研究进展
Publicado: (2016)